A
Andrew D. Ellington
Researcher at University of Texas at Austin
Publications - 599
Citations - 48723
Andrew D. Ellington is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Aptamer & RNA. The author has an hindex of 96, co-authored 569 publications receiving 43262 citations. Previous affiliations of Andrew D. Ellington include Harvard University & UPRRP College of Natural Sciences.
Papers
More filters
Journal ArticleDOI
In vitro selection of proteins via emulsion compartments.
Wei Cheng Lu,Andrew D. Ellington +1 more
TL;DR: A variety of mechanisms by which proteins and RNA can attach to or amplify their own templates following emulsification and selection are presented.
Journal ArticleDOI
Coupling Two Different Nucleic Acid Circuits in an Enzyme-Free Amplifier
TL;DR: A catalytic hairpin assembly circuit is used to initiate a hybridization chain reaction (HCR) circuit and each process yielded 10-fold signal amplification in a convenient 96-well format.
Journal ArticleDOI
Peptide-templated nucleic acid ligation.
Matthew Levy,Andrew D. Ellington +1 more
TL;DR: The results support the possibility that life could have originated with peptide replicators and transitioned to nucleic acid replicators or that peptide and nucleic acids replicators could have been interdependent.
Journal ArticleDOI
Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein
Kamyab Javanmardi,Thomas H. Segall-Shapiro,Chia Wei Chou,Daniel R. Boutz,Randall J. Olsen,Xuping Xie,Hongjie Xia,Pei Yong Shi,Charlie D. Johnson,Ankur Annapareddy,Scott C. Weaver,James M. Musser,Andrew D. Ellington,Ilya J. Finkelstein,Jimmy Gollihar +14 more
TL;DR: In this article , the authors characterized the molecular effects of the Omicron spike mutations on expression, ACE2 receptor affinity, and neutralizing antibody recognition of the SARS-CoV-2.
Journal ArticleDOI
Deoxyribozymes that recode sequence information
TL;DR: E engineered binary deoxyribozyme ligases whose two components are brought together by bridging oligonucleotide effectors can ‘read’ one sequence and then ‘write’ a separate, distinct sequence, which can in turn be uniquely amplified.